Page last updated: 2024-12-05

dodecanedioic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dodecanedioic acid, also known as 1,12-dodecanedioic acid, is a dicarboxylic acid with the formula HOOC(CH2)10COOH. It is a white, crystalline solid that is soluble in hot water and organic solvents. Dodecanedioic acid is a naturally occurring compound found in some plants, and it can also be synthesized. It is used in the production of nylon, polyester, and other polymers. Dodecanedioic acid is also used as a plasticizer, a lubricant, and a corrosion inhibitor.'

dodecanedioic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dodecanedioic acid : An alpha,omega-dicarboxylic acid that is dodecane in which the methyl groups have been oxidised to the corresponding carboxylic acids. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12736
CHEMBL ID3182356
CHEBI ID4676
SCHEMBL ID29467
MeSH IDM0111872

Synonyms (67)

Synonym
1, 10-decanedicarboxylic acid
LMFA01170009
1,12-dodecanedioic acid
nsc400242
nsc-400242
decamethylenedicarboxylic acid
1,10-decanedicarboxylic acid
dodecanedioic acid
693-23-2
C02678
dodecanedioic acid, 99%
NCGC00163995-01
hsdb 5745
nsc 400242
einecs 211-746-3
CHEBI:4676 ,
1,10-dicarboxydecane
AC-10611
D0013
NCGC00163995-02
tox21_303308
dtxcid607297
dtxsid3027297 ,
NCGC00257191-01
cas-693-23-2
NCGC00259503-01
tox21_201954
dodecandioic acid
978yu42q6i ,
ec 211-746-3
unii-978yu42q6i
FT-0606028
BBL018825
AKOS015892807
S6267
n-dodecane-.alpha.,.omega.-dioic acid
dodecanedioic acid [hsdb]
dodecanedioic acid [inci]
SCHEMBL29467
n-dodecanedioic acid
1,10-dicarboxy decane
dodecane dioic acid
dodecanedioicacid
CHEMBL3182356
mfcd00002735
decane-1,10-dicarboxylic acid
F16287
Z2044738279
1,10-decanedicarboxylate
sl-ah
decamethylenedicarboxylate
n-dodecanedioate
1,12-dodecanedioate
n-dodecane-a,w-dioate
corfree m 2
n-dodecane-a,w-dioic acid
CS-W012957
HY-W012241
1,12-dodecanedioic-d20 acid
Q5287812
DS-18055
STL195386
SB74075
1,12-dodecanedioic acid; 1,10-decanedicarboxylic acid; decamethylenedicarboxylic acid
53037-60-8
EN300-1081985
n-dodecane-alpha,omega-dioic acid

Research Excerpts

Overview

Dodecanedioic acid (C12) is an even-numbered dicarboxylic acid (DA)

ExcerptReferenceRelevance
"Dodecanedioic acid (C12) is an even-numbered dicarboxylic acid (DA). "( The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients.
Benedetti, G; Capristo, E; De Gaetano, A; Gasbarrini, G; Greco, AV; Mingrone, G, 1998
)
2.05

Pharmacokinetics

ExcerptReferenceRelevance
"Dodecanedioic acid (C12), a saturated, aliphatic dicarboxylic acid with 12 carbon atoms, was given as an intravenous bolus (800 mumol/kg of body weight [kgBW]) in male Wistar rats to study its pharmacokinetic profile."( Pharmacokinetic profile of dodecanedioic acid, a proposed alternative fuel substrate.
Castagneto, M; De Gaetano, A; Greco, AV; Mingrone, G; Raguso, C; Tataranni, A,
)
1.87

Dosage Studied

ExcerptRelevanceReference
" Excretion was also independent of dosage in rats."( Metabolism of straight saturated medium chain length (C9 to C12) dicarboxylic acids.
Fasella, P; Mingrone, G; Nazzaro-Porro, M; Passi, S; Picardo, M, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.1.1.1 (alcohol dehydrogenase) inhibitorAn EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of alcohol dehydrogenase (EC 1.1.1.1).
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
alpha,omega-dicarboxylic acid
dicarboxylic fatty acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
SMAD family member 2Homo sapiens (human)Potency0.15490.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency0.15490.173734.304761.8120AID1346859
GLI family zinc finger 3Homo sapiens (human)Potency70.90090.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency14.74640.000221.22318,912.5098AID1259243; AID1259247; AID743036
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency24.53460.013326.981070.7614AID1346978
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency0.00100.001022.650876.6163AID1224838
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency38.54040.001530.607315,848.9004AID1224841; AID1224842; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.22250.000229.305416,493.5996AID743069; AID743075; AID743079
caspase-3Homo sapiens (human)Potency24.53460.013326.981070.7614AID1346978
histone deacetylase 9 isoform 3Homo sapiens (human)Potency19.89570.037617.082361.1927AID1259364; AID1259388
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (32.69)18.7374
1990's10 (19.23)18.2507
2000's13 (25.00)29.6817
2010's9 (17.31)24.3611
2020's3 (5.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.69 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index72.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.51%)5.53%
Reviews1 (1.75%)6.00%
Case Studies3 (5.26%)4.05%
Observational0 (0.00%)0.25%
Other51 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]